Trevor Clancy, Ph.D. is the Chief Scientific Officer & Co-founder of OncoImmunity. Dr. Clancy has a PhD degree in cancer bioinformatics from the University of Oslo. He has an immunological background developing computational immune-profiling methods, in several national and international cancer related projects. Dr. Clancy has more than 13 years experience in bioinformatics and 7 years of commercial experience in bioinformatics product development. He has an active scientific profile in applying immune informatics for biomarker discovery in cancer.